1315 Capital.
Follow 1315 Capital1315 Capital is a Philadelphia-based private investment firm with over $1 billion of assets under management that provides growth capital to commercial-stage healthcare services, outsourced pharma and medtech services, healthcare products and wellness companies. It makes both minority and majority investments.[1]
Firm profile
- Strategy
For Carrywatch Pro members.
- Geography
For Carrywatch Pro members.
- Portfolio companies
1 deal on Carrywatch. For Carrywatch Pro members.
Deals on Carrywatch
Every deal that names 1315 Capital, and its role in each.
1315 Capital / Argonaut's Life Sciences and Diagnostics division (now Aluris Sciences)
1315 Capital completed the acquisition of Argonaut Manufacturing Services' Life Sciences and Diagnostics division on Sep 9, with the unit now operating independently as Aluris Sciences.
See deal detailsIdentity
- Legal name
- 1315 Capital, LLC Adviser registration 24 Mar 2026
- Registration
- Registered adviser
- CRD
- 175292
- File number
- 801-118283
Portfolio
| Company | Status | Deal | Date | Source |
|---|---|---|---|---|
| Aluris Sciences | Current | 1315 Capital / Argonaut's Life Sciences and Diagnostics division (now Aluris Sciences) | 13 Sep 2026 | x.com 13 Sep 2026 |
Deal Web
1315 Capital and 2 firms it shares a posted deal with, and the path to any other firm.
News
Loading headlines.
Sources
As of 25 Sep 2026.
- 01Argonaut Manufacturing Services Divests Life Sciences and Diagnostics Division to 1315 Capital
BioSpace (Argonaut Manufacturing Services press release) · Researched 25 Sep 2026
Deal posts naming 1315 Capital:
- P01